Kimberly-Clark to Acquire Tylenol Maker Kenvue in $48.7 Billion Deal

The consumer goods company agreed to purchase healthcare products manufacturer Kenvue, known for Tylenol, in a transaction valued at $48.7 billion.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Acquisition: A corporate transaction where one company purchases most or all of another company's shares or assets to gain control.
  • Consumer goods company: A business that produces products used by everyday consumers, such as food, beverages, personal care, and household items.
  • Kenvue: A healthcare products manufacturer known for Tylenol and other over-the-counter medicines.